No Data
No Data
Willow Biosciences Projecting Over $1M in 2Q Revenue | TSX:WLLW, OTCQB:CANSF
Willow Biosciences Brief: Announced Multi-product Development and Licensing Partnership With Laurus Labs for Manufacturing Active Pharmaceutical Ingredients
04:33 PM EDT, 06/26/2024 (MT Newswires) -- Willow Biosciences Brief: Announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients
Willow Biosciences Brief: Announces Its First Patent Being Issued; Anticipates Filing Another Five Patents in 2024 Primarily Related to Its Steroid Production Platform
04:32 PM EDT, 06/26/2024 (MT Newswires) -- Willow Biosciences Brief: Announces its first patent being issued; Anticipates filing another five patents in 2024 primarily related to its steroid productio
Willow Bioscience Announces 3 Million Dollar Fundraising to Support Partnership With Laurus Labs | TSX:WLLW, OTCQB:CANSF
Willow Biosciences to Launch a $3m Brokered Placement | TSX:WLLW, OTCQB:CANSF
Press Release: WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Canada NewsWire SUNNYVALE, Calif., May 13, 2024 Company continues to advance its corticosteroid product